comparemela.com

Latest Breaking News On - Avinger inc - Page 1 : comparemela.com

Avinger (NASDAQ:AVGR) Coverage Initiated by Analysts at StockNews com

StockNews.com initiated coverage on shares of Avinger (NASDAQ:AVGR – Free Report) in a research note published on Sunday morning. The firm issued a hold rating on the medical device company’s stock. Separately, HC Wainwright reaffirmed a buy rating and set a $5.00 target price on shares of Avinger in a report on Thursday, March 21st. […]

Short Interest in Avinger, Inc (NASDAQ:AVGR) Decreases By 32 5%

Short Interest in Avinger, Inc (NASDAQ:AVGR) Decreases By 32 5%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Avinger (NASDAQ:AVGR) Research Coverage Started at StockNews com

StockNews.com initiated coverage on shares of Avinger (NASDAQ:AVGR – Free Report) in a report issued on Sunday. The brokerage issued a hold rating on the medical device company’s stock. Separately, HC Wainwright reaffirmed a buy rating and set a $5.00 price target on shares of Avinger in a research note on Thursday, March 21st. View […]

Avinger (NASDAQ:AVGR) Earns Hold Rating from Analysts at StockNews com

StockNews.com began coverage on shares of Avinger (NASDAQ:AVGR – Free Report) in a research report released on Saturday. The firm issued a hold rating on the medical device company’s stock. Separately, HC Wainwright restated a buy rating and set a $5.00 price target on shares of Avinger in a research note on Thursday, March 21st. […]

Avinger Announces Conversion of $11 Million of CRG Debt into Preferred Equity

REDWOOD CITY, CA / ACCESSWIRE / May 16, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today announced the conversion of $11 million or approx.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.